EUVIMEDEUVIMED entdecken
Crossref

Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway

Yonghua Li, Yibing Chen, Yuan Liao, Ting Huang, Qing Tang, Chengsi He, Liu Xu, Haocai Chang, Hongsheng Li, Quentin Liu, Dongming Lai, Qing Xia und 1 weitere

Apoptosis · 2024-06 · 29 (5-6) · 663-680

DOI: 10.1007/s10495-024-01949-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, online erschienen am 10.04.2024. Verfasst von Yonghua Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou, 510631…. Hauptthemen laut MEDLINE: Cachexia, Muscular Diseases, Neoplasms, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Natural Science Foundation of Guangdong ¾province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cachexia-associated muscle wasting as a multifactorial wasting syndrome, is an important factor affecting the long-term survival rate of tumor patients. Photobiomodulation therapy (PBMT) has emerged as a promising tool to cure and prevent many diseases. However, the effect of PBMT on skeletal muscle atrophy during cancer progression has not been fully demonstrated yet. Here, we found PBMT alleviated the atrophy of myotube diameter induced by cancer cells in vitro, and prevented cancer-associated muscle atrophy in mice bearing tumor. Mechanistically, the alleviation of muscle wasting by PBMT was found to be involved in inhibiting E3 ubiquitin ligases MAFbx and MuRF-1. In addition, transcriptomic analysis using RNA-seq and GSEA revealed that PI3K/AKT pathway might be involved in PBMT-prevented muscle cachexia. Next, we showed the protective effect of PBMT against muscle cachexia was totally blocked by AKT inhibitor in vitro and in vivo. Moreover, PBMT-activated AKT promoted FoxO3a phosphorylation and thus inhibiting the nucleus entry of FoxO3a. Lastly, in cisplatin-treated muscle cachexia model, PBMT had also been shown to ameliorate muscle atrophy through enhancing PI3K/AKT pathway to suppress MAFbx and MuRF-1 expression. These novel findings revealed that PBMT could be a promising therapeutic approach in treating muscle cachexia induced by cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaMuscular DiseasesNeoplasmsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktForkhead Box Protein O3Wasting SyndromeMetabolic Networks and PathwaysAnimalsDisease Models, AnimalMiceCell LineMaleMice, Inbred BALB CGene Expression Profiling

Stichwörter der Autor:innen

Cancer cachexiaE3 ubiquitin ligasesMuscle wastingPBMTPI3K/AKT pathway

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktForkhead Box Protein O3

Autor:innen und Institutionen

  • MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou, 510631, China.
  • Genetic and Prenatal Diagnosis Center, Department of Gynecology and Obstetrics, First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China.
  • Department of Laboratory Medicine, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
  • Department of Breast Surgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510631, China.
  • Department of Gastrointestinal Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510235, China. laidm@mail.sysu.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong ¾province

Zitieren

APA

Li, Y., Chen, Y., Liao, Y., Huang, T., Tang, Q., He, C., Xu, L., Chang, H., Li, H., Liu, Q., Lai, D., Xia, Q., & Zou, Z. (2024). Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway. Apoptosis, 29(5-6), 663-680. https://doi.org/10.1007/s10495-024-01949-2

Vancouver

Li Y, Chen Y, Liao Y, Huang T, Tang Q, He C, et al. Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway. Apoptosis. 2024;29(5-6):663-680. doi:10.1007/s10495-024-01949-2

BibTeX
@article{Li2024,
  author = {Li, Yonghua and Chen, Yibing and Liao, Yuan and Huang, Ting and Tang, Qing and He, Chengsi and Xu, Liu and Chang, Haocai and Li, Hongsheng and Liu, Quentin and Lai, Dongming and Xia, Qing and Zou, Zhengzhi},
  title = {Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway},
  journal = {Apoptosis},
  year = {2024},
  volume = {29},
  number = {5-6},
  pages = {663--680},
  doi = {10.1007/s10495-024-01949-2}
}
Kostenlos starten →